Get to know our clinical trials

Retrospective review of medical records to evaluate the diagnosis according to stage and resectability status, and the first line of treatment of advanced melanoma in 4 reference centers in Spain.

Imagen Dr. Salvador Martín Algarra, Departamento de Oncología Médica
Dr. Salvador Martin Algarra Curriculum
Specialist Medical Oncology Department
Navarre headquarters
Diseases
Melanoma
Status
In recruitment
headquarters
Pamplona

Technical Summary

  • RETROSPECTIVE REVIEW OF MEDICAL RECORDS TO EVALUATE THE DIAGNOSIS ACCORDING TO STAGE AND RESECTABILITY STATUS, AND THE FIRST LINE OF TREATMENT OF ADVANCED MELANOMA IN 4 REFERENCE CENTERS IN SPAIN.
  • Protocol number: 20150299
  • Promoter: Amgen, S.A.
  • Link to Clinical Trials

* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.